Related Experiment Video
Updated: Feb 15, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Noninfectious aortitis: Experience with tocilizumab in a regional hospital
Vicente Aldasoro Cáceres1, Rosario Ibáñez Bosch1, Nathalí Rivas Zavaleta2
1Complejo Hospitalario de Navarra, Pamplona, España.
Objectives:
Describe patients with noninfectious aortitis and their response to treatment in a regional hospital.
Methods:
Review of patients with noninfectious aortitis, diagnostic technique used and immunosuppressive therapy received.
Results:
We report 8 patients (7 women and one man) diagnosed with aortitis by positron emission tomography (PET). The mean age was 69years (interquartile range [IQR] 62-72.2). Three months of treatment with tocilizumab improved symptoms, erythrocyte sedimentation rate and C-reactive protein level (P<.001 and P<.012, respectively) in the 6 patients in whom it was used.
Conclusions:
Tocilizumab was an effective and safe treatment in those patients diagnosed with aortitis refractory to steroids and conventional immunosuppressive therapy.
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
IR Frequency Region: Fingerprint Region
What is an Experiment?
The Eukaryotic Promoter Region
Region of Convergence

